NCT07157956 - CVL006 Combination Therapy in Advanced Solid Tumors | Biotech Hunter

Enrollment

318

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

August 12, 2028

Study Completion Date

December 30, 2028

Conditions

Advanced Solid Tumor

Interventions

DRUG

CVL006 combined with pemetrexed and carboplatin

DRUG

CVL006 in combination with SKB264

DRUG

CVL006 in combination with DS-8201

DRUG

CVL006 in combination with Enfortumab Vedotin

Trial Locations (1)

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Convalife (Shanghai) Co., Ltd.

INDUSTRY